GENTERA:BMVGentera SAB de CV Analysis
Data as of 2026-03-15 - not real-time
MX$47.08
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Gentera trades at MXN 47.08, comfortably above its 20‑day SMA of 50.53 but below the 50‑day SMA of 49.61, indicating a modest bullish bias while still leaving room for upside. The 14‑day RSI sits at 38.6, suggesting the stock is approaching oversold territory and could rebound toward the resistance level of MXN 54.70. Technical momentum is mixed: the MACD histogram is negative and the signal line is bearish, yet the overall trend direction is flagged as bullish and volume is increasing. On the valuation side, the price‑to‑earnings ratio of 9.4 is well under the industry average of 16.35, and the DCF‑derived fair value of MXN 9.68 points to a substantial discount, translating to an estimated upside of roughly 13 % versus the current price. The company delivers a solid dividend yield of 3.22 % with a modest payout ratio of 30 %, backed by MXN 17.7 bn of cash and a debt‑to‑equity profile that is effectively neutral. With a market cap of MXN 74.35 bn, low beta (0.272) and a 30‑day volatility of 35 %, Gentera offers a blend of growth (14 % revenue expansion) and value characteristics, supported by strong operating margins and a 24.5 % ROE.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish alignment of SMA 20 above SMA 50 and SMA 200
- Price near support at MXN 46.27 with increasing volume
- RSI indicating oversold conditions and potential rebound
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued P/E relative to industry peers
- Strong operating margin (33.9 %) and ROE (24.5 %)
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Demographic tailwinds in Mexico and Peru driving micro‑credit demand
- Consistent dividend policy supporting shareholder returns
- Robust cash generation and low leverage enhancing financial stability
Key Metrics & Analysis
Financial Health
Revenue Growth14.40%
Profit Margin22.53%
P/E Ratio9.4
ROE24.50%
ROA7.50%
P/B Ratio2.1
Op. Cash FlowMX$2.8B
Industry P/E16.4
Technical Analysis
TrendBullish
RSI38.6
SupportMX$46.27
ResistanceMX$54.70
MA 20MX$50.53
MA 50MX$49.61
MA 200MX$45.19
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair ValueMX$9.68
Target PriceMX$53.29
Upside/Downside13.18%
GradeUndervalued
TypeBlend
Dividend Yield3.22%
Risk Assessment
Beta0.65
Volatility35.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.